Special sessions
Plenary lectures
Main Symposia
Committee sessions
Research group sessions
Sponsored sessions
Corporate symposia
| SP1 KDA & KVBM joint session : Overcoming diabetic vascular diseases |
15:00~17:00 / Thursday 6 October Convention Hall B, 4F Chairman:Jaetaek Kim, Hyuk-Sang Kwon |
Overview |
|---|---|---|
| Vascular diseases associated with diabetes are the leading cause of multi-organ damage, including renal failure, blindness, a variety of neuropathies, and atherosclerosis, and account for disabilities and high mortality rates in patients with diabetes. This joint session in collaboration with the Korean Society for Vascular Biology and Medicine (KVBM) will provide novel perspectives to overcome vascular complications by dissecting cellular dysfunction and molecular pathogenesis in cardio- and cerebral-vascular diseases. | ||
|
SP1-1 Targeting endothelial dysfunction in diabetes | |
|
SP1-2 New insights on cardio-renal protective mechanism of SGLT2 inhibitors: ketones and inflammasome | |
|
SP1-3 Key role of Drp1-KLF4 engagement on vascular smooth muscle cell function | |
|
SP1-4 Cerebrovascular recovery mechanism via neurovascular signaling | |
| SP2 Basic research hot topic session : Single technology for metabolism study |
15:00~17:00 / Thursday 6 October Emerald Hall B, 3F Chairman:Jongsoon Lee, Minho Shong |
Overview |
|---|---|---|
| Rapid progress in developing next-generation sequencing (NGS) technologies has provided valuable insights into complex biological systems in metabolic diseases. NGS-based technologies for genomics, transcriptomics, and epigenomics are now mainly focused on the characterization of individual cells. These single-cell analyses will allow clinicians and researchers to reveal new and potentially unexpected biological discoveries in disease progression. For example, single-cell RNA sequencing (scRNA-seq) can uncover complex and rare cell populations, discover regulatory relationships between genes, and track the trajectories of distinct cell lineages in development and diseases. In this section, four speakers will discuss the relative strengths and weaknesses of various scRNA-seq technologies and the roles of multiple cells in disease progression and development. | ||
|
SP2-1 Single-cell fate decision in development and diseases | |
|
SP2-2 Single-cell analysis of mouse pancreatic islet for study of progressive β-cell failure | |
|
SP2-3Dissecting cellular heterogeneity and plasticity in adipose tissues | |
|
SP2-4A study on the relationship between type 2 diabetes mellitus and periodontitis through single cell transcriptome analysis | |
| SP3 KDA & KRS joint session : Past, present, and future collaborations for diabetic retinopathy |
16:00~18:00 / Friday 7 October Convention Hall C, 4F Chairman:Kyu Chang Won, June-Gone Kim |
Overview |
|---|---|---|
| Diabetic retinopathy is the leading cause of vision loss and is the most affected complication of glycemic control. Effective management through closer cooperation between diabetologists and retinal specialists is required to prevent blindness in diabetic patients. This joint session between Korean Retina Society and Korean Diabetes Association will review the updated evidence on the treatment and pathogenesis of diabetic retinopathy and discuss how to improve the management of diabetic retinopathy. | ||
|
SP3-1Monitoring of retinopathy progression from diabetologists' perspective | |
|
SP3-2Management of diabetic metabolic status from retinal specialists' perspective | |
|
SP3-3Clinical evidence of medical treatments for patients with diabetic retinopathy | |
|
SP3-4Updates in pathogenesis and future treatments of diabetic retinopathy | |
|
SP3-Panel 1Panel discussion | |
|
SP3-Panel 2Panel discussion | |
|
SP3-Panel 3Panel discussion | |
|
SP3-Panel 4Panel discussion | |
